The biopharmaceutical production plant H84 of the Boehringer Ingelheim Pharma GmbH & Co.KG (limited partnership with a limited liability company as general partner) has been run since 1986.
The biopharmaceutical production plant H84 of the Boehringer Ingelheim Pharma GmbH & Co.KG has been run since 1986. In order to adapt the company’s infrastructure to future developments, an annex was added to the plant and a great part of the equipment had been modernized.
The following equipment had been installed in the annex:
- production areas for fermentation purposes and protein chemistry production meeting clean room standards
- equipment for producing and distributing purified/filtrated pharmaceutical drugs
- production area → technical building services
Sections of the ventilation system had been restructured; the movement of personnel and the flow of materials had both been optimized. The existing air-conditioning system was modernized and an additional ventilation system was installed. The plant’s fire protection system had been expanded and replaced by modern technology. The construction of the annex and new installations within the plant had been performed during day-to-day business. The replacement, expansion and connection of new installations had been completed within three months of service interruption.